Table:
Baseline	Melatonin Supplementation
AI	6.2 (3.8–22.5)	5.8 (3.3–33.5)
AHI	7.6 (3.6–57.7)	3.5 (1.2–48.6)
Stage 1%	1.3 (0–4.4)	2.2 (1.7–2.9)
Stage 2%	45.9 (32.7–68.7)	61.3 (40–68.5)
Stage 3%	15.8 (4.1–35.1)	19 (3.4–32.3)
Stage 4%	14.6 (0–30)	10.9 (0–13.4)
Stage REM%	13.1 (7.8–36.1)	14.2 (10.8–25.2)
REM latency	92 (63.5–169.5)	152.5 (66.5–213.5)
TST	332.5 (90–353.5)	338.5 (292–365)
SpO2 < 90%	0.6 (0–37.6)	0.8 (0.4–21.1)
# Awake times	7 (4–24)	7 (4–40)
Time spent awake	16 (6–149)	20 (5–136.5)

Parse the following content of the picture in markdown code: |  | Baseline | Melatonin Supplementation | 
 | --- | --- | --- | 
 | AI | 6.2 (3.8–22.5) | 5.8 (3.3–33.5) | 
 | AHI | 7.6 (3.6–57.7) | 3.5 (1.2–48.6) | 
 | Stage 1% | 1.3 (0–4.4) | 2.2 (1.7–2.9) | 
 | Stage 2% | 45.9 (32.7–68.7) | 61.3 (40–68.5) | 
 | Stage 3% | 15.8 (4.1–35.1) | 19 (3.4–32.3) | 
 | Stage 4% | 14.6 (0–30) | 10.9 (0–13.4) | 
 | Stage REM% | 13.1 (7.8–36.1) | 14.2 (10.8–25.2) | 
 | REM latency | 92 (63.5–169.5) | 152.5 (66.5–213.5) | 
 | TST | 332.5 (90–353.5) | 338.5 (292–365) | 
 | SpO2 < 90% | 0.6 (0–37.6) | 0.8 (0.4–21.1)

| 
 | # Awake times | 7 (4–24) | 7 (4–40) | 
 | Time spent awake | 16 (6–149) | 20 (5–136.5) |